Log in
Enquire now

List of Acura Pharmaceuticals patents

List of Acura Pharmaceuticals patents
List of BioGaia patents
List of Safran Transmission Systems patents
List of D-Wave Systems patents
List of companies in OTB Ventures's investment portfolio
List of companies in Qatar Investment Authority's investment portfolio
Patents where
Current Assignee
Name
is
Acura PharmaceuticalsAcura Pharmaceuticals
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 11554114 Methods and compositions for self-regulated release of active pharmaceutical ingredients

Patent 11554114 was granted and assigned to Acura Pharmaceuticals on January, 2023 by the United States Patent and Trademark Office.

Acura Pharmaceuticals
Acura Pharmaceuticals
Acura Pharmaceuticals
Acura Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
11554114
January 17, 2023
‌
US Patent 6949645 Process for the production of opiates

Patent 6949645 was granted and assigned to Acura Pharmaceuticals on September, 2005 by the United States Patent and Trademark Office.

Acura Pharmaceuticals
Acura Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
6949645
September 27, 2005
‌
US Patent 9662393 Methods and compositions for self-regulated release of active pharmaceutical ingredient

Patent 9662393 was granted and assigned to Acura Pharmaceuticals on May, 2017 by the United States Patent and Trademark Office.

Acura Pharmaceuticals
Acura Pharmaceuticals
Acura Pharmaceuticals
Acura Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
9662393
May 30, 2017
‌
US Patent 9320796 Methods and compositions for self-regulated release of active pharmaceutical ingredient

Patent 9320796 was granted and assigned to Acura Pharmaceuticals on April, 2016 by the United States Patent and Trademark Office.

Acura Pharmaceuticals
Acura Pharmaceuticals
Acura Pharmaceuticals
Acura Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
9320796
April 26, 2016
‌
US Patent 9101636 Methods and compositions for self-regulated release of active pharmaceutical ingredient

Patent 9101636 was granted and assigned to Acura Pharmaceuticals on August, 2015 by the United States Patent and Trademark Office.

Acura Pharmaceuticals
Acura Pharmaceuticals
Acura Pharmaceuticals
Acura Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
9101636
August 11, 2015
‌
US Patent 11083794 Methods and compositions for self-regulated release of active pharmaceutical ingredient

Patent 11083794 was granted and assigned to Acura Pharmaceuticals on August, 2021 by the United States Patent and Trademark Office.

Acura Pharmaceuticals
Acura Pharmaceuticals
Acura Pharmaceuticals
Acura Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
11083794
August 10, 2021
‌
US Patent 7201920 Methods and compositions for deterring abuse of opioid containing dosage forms

Patent 7201920 was granted and assigned to Acura Pharmaceuticals on April, 2007 by the United States Patent and Trademark Office.

Acura Pharmaceuticals
Acura Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
7201920
April 10, 2007
‌
US Patent 7510726 Methods and compositions for deterring abuse of opioid containing dosage forms

Patent 7510726 was granted and assigned to Acura Pharmaceuticals on March, 2009 by the United States Patent and Trademark Office.

Acura Pharmaceuticals
Acura Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
7510726
March 31, 2009
‌
US Patent 7476402 Methods and compositions for deterring abuse of opioid containing dosage forms

Patent 7476402 was granted and assigned to Acura Pharmaceuticals on January, 2009 by the United States Patent and Trademark Office.

Acura Pharmaceuticals
Acura Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
7476402
January 13, 2009
‌
US Patent 8409616 Extended release opioid abuse deterrent compositions and methods of making same

Patent 8409616 was granted and assigned to Acura Pharmaceuticals on April, 2013 by the United States Patent and Trademark Office.

Acura Pharmaceuticals
Acura Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
8409616
April 2, 2013
‌
US Patent 7071336 Process for manufacturing opioid analgesics

Patent 7071336 was granted and assigned to Acura Pharmaceuticals on July, 2006 by the United States Patent and Trademark Office.

Acura Pharmaceuticals
Acura Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
7071336
July 4, 2006
‌
US Patent 8101630 Extended release opioid abuse deterrent compositions and methods of making same

Patent 8101630 was granted and assigned to Acura Pharmaceuticals on January, 2012 by the United States Patent and Trademark Office.

Acura Pharmaceuticals
Acura Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
8101630
January 24, 2012
‌
US Patent 7981439 Methods and compositions for deterring abuse of drugs susceptible to abuse and dosage forms thereof

Patent 7981439 was granted and assigned to Acura Pharmaceuticals on July, 2011 by the United States Patent and Trademark Office.

Acura Pharmaceuticals
Acura Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
7981439
July 19, 2011
‌
US Patent 9757466 Methods and compositions for deterring abuse

Patent 9757466 was granted and assigned to Acura Pharmaceuticals on September, 2017 by the United States Patent and Trademark Office.

Acura Pharmaceuticals
Acura Pharmaceuticals
Acura Pharmaceuticals
Acura Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
9757466
September 12, 2017
‌
US Patent 10155044 Methods and compositions for deterring abuse

Patent 10155044 was granted and assigned to Acura Pharmaceuticals on December, 2018 by the United States Patent and Trademark Office.

Acura Pharmaceuticals
Acura Pharmaceuticals
Acura Pharmaceuticals
Acura Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
10155044
December 18, 2018
‌
US Patent 9492443 Abuse deterrent compositions and methods of making same

Patent 9492443 was granted and assigned to Acura Pharmaceuticals on November, 2016 by the United States Patent and Trademark Office.

Acura Pharmaceuticals
Acura Pharmaceuticals
Acura Pharmaceuticals
Acura Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
9492443
November 15, 2016
‌
US Patent 7348430 Production of opioid analgesics

Patent 7348430 was granted and assigned to Acura Pharmaceuticals on March, 2008 by the United States Patent and Trademark Office.

Acura Pharmaceuticals
Acura Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
7348430
March 25, 2008
‌
US Patent 10004699 Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse

Patent 10004699 was granted and assigned to Acura Pharmaceuticals on June, 2018 by the United States Patent and Trademark Office.

Acura Pharmaceuticals
Acura Pharmaceuticals
Acura Pharmaceuticals
Acura Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
10004699
June 26, 2018
‌
US Patent 10688184 Methods and compositions for self-regulated release of active pharmaceutical ingredient

Patent 10688184 was granted and assigned to Acura Pharmaceuticals on June, 2020 by the United States Patent and Trademark Office.

Acura Pharmaceuticals
Acura Pharmaceuticals
Acura Pharmaceuticals
Acura Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
10688184
June 23, 2020
‌
US Patent 8901113 Methods and compositions for deterring abuse

Acura Pharmaceuticals
Acura Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
8901113
December 2, 2014
‌
US Patent 11197837 Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse

Patent 11197837 was granted and assigned to Acura Pharmaceuticals on December, 2021 by the United States Patent and Trademark Office.

Acura Pharmaceuticals
Acura Pharmaceuticals
Acura Pharmaceuticals
Acura Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
11197837
December 14, 2021
‌
US Patent 10610497 Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse

Patent 10610497 was granted and assigned to Acura Pharmaceuticals on April, 2020 by the United States Patent and Trademark Office.

Acura Pharmaceuticals
Acura Pharmaceuticals
Acura Pharmaceuticals
Acura Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
10610497
April 7, 2020
‌
US Patent 11103581 Methods and compositions for self-regulated release of active pharmaceutical ingredient

Patent 11103581 was granted and assigned to Acura Pharmaceuticals on August, 2021 by the United States Patent and Trademark Office.

Acura Pharmaceuticals
Acura Pharmaceuticals
Acura Pharmaceuticals
Acura Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
11103581
August 31, 2021
‌
US Patent 6946556 Preparation of opioid analgesics by a one-pot process

Patent 6946556 was granted and assigned to Acura Pharmaceuticals on September, 2005 by the United States Patent and Trademark Office.

Acura Pharmaceuticals
Acura Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
6946556
September 20, 2005
‌
US Patent 6972332 Process for the production of opiates

Patent 6972332 was granted and assigned to Acura Pharmaceuticals on December, 2005 by the United States Patent and Trademark Office.

Acura Pharmaceuticals
Acura Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
6972332
December 6, 2005
Results per page:
27 results
0 selected
27 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us